Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

about

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.PFO closure: End of an era or beginning of a new chapter?Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up.

P2860

Q45173428-1A4A70B9-19C6-45D5-92EF-0ABA386804F5 Q48062407-1CA7FBE2-E6C4-40F4-B792-582942DFBF8B Q49452914-F97FE1FF-AF2C-4C85-81EA-8217C62CBC26

P2860

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

Item

http://www.wikidata.org/entity/Q39878127

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Long-term follow-up after PFO ...... in a Single-center Experience.

@en

Long-term follow-up after PFO ...... in a Single-center Experience.

@nl

type

Item

label

Long-term follow-up after PFO ...... in a Single-center Experience.

@en

Long-term follow-up after PFO ...... in a Single-center Experience.

@nl

prefLabel

Long-term follow-up after PFO ...... in a Single-center Experience.

@en

Long-term follow-up after PFO ...... in a Single-center Experience.

@nl

P1476

Long-term follow-up after PFO ...... in a Single-center Experience.

@en

P2093

Allison K Cabalka

http://www.w3.org/2001/XMLSchema#string

Donald J Hagler

http://www.w3.org/2001/XMLSchema#string

Guy S Reeder

http://www.w3.org/2001/XMLSchema#string

Joshua P Slusser

http://www.w3.org/2001/XMLSchema#string

Monique A Freund

http://www.w3.org/2001/XMLSchema#string

Nathaniel W Taggart

http://www.w3.org/2001/XMLSchema#string

Ryan J Lennon

http://www.w3.org/2001/XMLSchema#string

P2860

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.

Prevalence of patent foramen ovale in patients with stroke.

Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

P304

124-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.26518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank Cetta

P577

2016-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27027873

http://www.w3.org/2001/XMLSchema#string

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

about

P2860

P2860

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698